SPPS (Solid-Phase Peptide Synthesis)

Solid-phase peptide synthesis (SPPS) is the dominant technique for chemical production of short to medium peptides (up to 50-70 amino acids). Invented by Bruce Merrifield in 1963, it earned him the Nobel Prize in Chemistry in 1984 and revolutionized molecular biology by making synthetic peptides accessible in pure, reproducible and modifiable form.

The principle relies on covalent anchoring of the first amino acid (C-terminal) to an insoluble solid resin, typically a functionalized polystyrene bead. The peptide chain then grows amino acid by amino acid from the C-terminal to the N-terminal, through repetitive addition cycles. Each cycle comprises four steps: N-terminal deprotection of the growing chain, washing, coupling of a new protected amino acid activated by a coupling agent (HBTU, HATU, DIC/HOBt), then washing again to eliminate excess reagents and byproducts.

Two chemical strategies coexist depending on the protecting group used on the α-amine function. The historical Boc (tert-butyloxycarbonyl) strategy employs deprotection by TFA and final cleavage by extremely toxic gaseous HF. The Fmoc (9-fluorenylmethoxycarbonyl) strategy, gentler and now standard, uses bases (piperidine) for deprotection and allows final cleavage by TFA alone. Virtually all modern commercial peptides are produced by Fmoc-SPPS, including complex peptides like semaglutide.

Industrial advantages of SPPS are considerable: complete automation on robotic synthesizers, usable reagent molar excesses to drive each coupling toward completion, efficient washes without product loss since it is immobilized on resin, parallelization possible to simultaneously produce multiple peptides. Coupling yield commonly reaches 99%, but overall yield remains the product of all individual yields: for a 40-residue peptide, an average 99% coupling gives a crude yield of approximately 67%, requiring chromatographic purification (preparative HPLC) to reach 98-99% pharmaceutical purity.

SPPS limits appear for long, aggregating or difficult-residue-rich sequences (glycine runs, hidden β-sheet regions). Mitigation strategies exist: pseudoprolines, side-chain-protected residues, double coupling, convergent synthesis via chemical ligation. Peptides offered on lab-peptides-france.com are produced by professional laboratories mastering these optimizations; our published analyses are available on the relevant product pages.